# Prevalence of hyperemesis gravidarum and its associated electrolyte and hematologic disturbances in pregnant women

**Authors:** Heba Bassiony Ghanem, Shaher Mustafa Hammoudeh, Moaz Abulfaraj, Dalia Mahmoud Abdelmonem Elsherbini, Sanaa Elfatih Hussein, Jamila Ibrahim Algader, Raghad Mohammed Alanazi, Taif Yahya Alshammari, Amirah Enad Alruwaili, Najd Budayri Alruwaili, Mohamed El-Sherbiny, Ahmed Baker A. Alshaikh, Maged Elshamy, Mohamed Mahmoud Abdelfattah Abdelrahman, Nagwan Ahmed Bahgat

PMC · DOI: 10.3389/fmed.2026.1703120 · Frontiers in Medicine · 2026-02-23

## TL;DR

This study examines how common hyperemesis gravidarum is in pregnant women and its effects on electrolytes and blood parameters.

## Contribution

The study provides prevalence data and identifies risk factors and complications of hyperemesis gravidarum in a specific Saudi Arabian region.

## Key findings

- Hyperemesis gravidarum prevalence was 1.1% among pregnant women in Aljouf, Saudi Arabia.
- HG cases showed lower weight, BMI, and higher rates of hypotension and electrolyte imbalances compared to controls.

## Abstract

Hyperemesis gravidarum (HG) is a condition that develops early in pregnancy, before 16 weeks of gestation, and is characterized by severe nausea and/or vomiting, inability to tolerate food and/or beverages, and substantial impairment of daily activities. Hyperemesis gravidarum can have obvious maternal and fetal consequences. This study aimed to assess the prevalence of HG, investigate its associated electrolyte and hematologic disturbances, and identify risk factors among pregnant women in Aljouf, Saudi Arabia.

A retrospective observational case-control study was conducted using 200 medical records selected from a total of 9,090 records of pregnant women at the Maternity and Children Hospital in Aljouf, covering the period from November 2020 to November 2023.

The prevalence of hyperemesis gravidarum was 1.1% among the studied pregnant women. Patients diagnosed with hyperemesis gravidarum showed significantly lower body weight and BMI than controls. Nearly 48% of HG cases occurred in women aged 30–39 years, while 52% were in the first trimester. Furthermore, 36% of the affected women were primigravida, and 11% were pregnant with twins. Hypotension was observed in 35% of HG cases. Hyponatremia occurred in 29% of patients, hypokalemia in 21%, and hypochloremia in 24%. Hematological disturbances included increased Hb levels in 11% of cases, increased hematocrit in 12%, leukocytosis in 19%, and neutrophilia in 17% of the patients.

Hypotension, electrolyte imbalance, and hematological disturbances are the primary consequences of HG. First-trimester pregnancy and low gestational age are the most important risk factors for HG. Strategies by healthcare centers and further research are needed to enhance the treatment, management, and prevention methods of HG.

## Linked entities

- **Diseases:** hyperemesis gravidarum (MONDO:0006791)

## Full-text entities

- **Genes:** GDF15 (growth differentiation factor 15) [NCBI Gene 9518] {aka GDF-15, HG, MIC-1, MIC1, NAG-1, PDF}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, GHRL (ghrelin and obestatin prepropeptide) [NCBI Gene 51738] {aka MTLRP}
- **Diseases:** PTBs (MESH:D047928), diabetes mellitus (MESH:D003920), abortion (MESH:D000026), muscle weakness (MESH:D018908), postural hypotension (MESH:D007024), HG (MESH:D006939), dehydration (MESH:D003681), weight loss (MESH:D015431), vitamin deficiencies (MESH:D014802), lethargy (MESH:D053609), leukocytosis (MESH:D007964), Anorexia (MESH:D000855), Wernicke encephalopathy (MESH:D014899), hypovolemia (MESH:D020896), acidosis (MESH:D000138), Hyponatremia (MESH:D007010), anxiety (MESH:D001007), anemia (MESH:D000740), liver diseases (MESH:D008107), headache (MESH:D006261), acute and chronic inflammation (MESH:D007249), cramping (MESH:D009120), thiamine deficiency (MESH:D013832), hypertension (MESH:D006973), encephalopathy (MESH:D001927), Hematological disturbances (MESH:D006402), ataxia (MESH:D001259), death (MESH:D003643), fluid loss (MESH:D002559), neutrophilia (MESH:C563010), premature labor (MESH:D007752), Hypotension (MESH:D007022), convulsions (MESH:D012640), alkalosis (MESH:D000471), post-traumatic stress disorder (MESH:D013313), vomiting (MESH:D014839), autonomic (MESH:D001342), Nutritional deficits (MESH:D009748), underweight (MESH:D013851), thyroid disorders (MESH:D013959), weight gain (MESH:D015430), Nausea and vomiting (MESH:D020250), gastric or intestinal diseases (MESH:D013274), nausea (MESH:D009325), depression (MESH:D003866), renal diseases (MESH:D007674), hypokalemia (MESH:D007008), fatigue (MESH:D005221), vertigo (MESH:D014717), confusion (MESH:D003221)
- **Chemicals:** Cl (MESH:D002713), aldosterone (MESH:D000450), K, and Cl (-), K (MESH:D011188), Na (MESH:D012964), progesterone (MESH:D011374), hydrochloric acid (MESH:D006851)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968194/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968194/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968194/full.md

---
Source: https://tomesphere.com/paper/PMC12968194